Ketcham; John Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ketcham; John Michael.The latest application filed is for "imidazo[1,2-c]pyrimidine derivatives as prc2 inhibitors for treating cancer".
- Ketcham; John Michael - San Diego CA
- Ketcham; John Michael - San Mateo CA
- Ketcham; John Michael - Carlsbad CA
| Patent | Date |
|---|---|
| KRas G12D inhibitors Grant 11,453,683 - Wang , et al. September 27, 2 | 2022-09-27 |
| Imidazo[1,2-c]pyrimidine Derivatives As Prc2 Inhibitors For Treating Cancer App 20220274990 - MARX; Matthew Arnold ; et al. | 2022-09-01 |
| Chemokine receptor modulators and uses thereof Grant 11,384,064 - Jackson , et al. July 12, 2 | 2022-07-12 |
| Naphthyridine Derivatives As Prc2 Inhibitors App 20220213097 - KETCHAM; John Michael ; et al. | 2022-07-07 |
| Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Grant 11,220,509 - Marx , et al. January 11, 2 | 2022-01-11 |
| Chemokine receptor modulators and uses thereof Grant 11,192,879 - Jackson , et al. December 7, 2 | 2021-12-07 |
| Ubiquitin-specific-processing Protease 7 (usp7) Modulators And Uses Thereof App 20210317134 - Schwarz; Jacob Bradley ; et al. | 2021-10-14 |
| Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Grant 11,091,495 - Marx , et al. August 17, 2 | 2021-08-17 |
| Prc2 Inhibitors App 20210230168 - MARX; Matthew Arnold ; et al. | 2021-07-29 |
| Sos1 Inhibitors App 20210188857 - Marx; Matthew Arnold ; et al. | 2021-06-24 |
| Prc2 Inhibitors App 20210101904 - MARX; Matthew Arnold ; et al. | 2021-04-08 |
| MTA-Cooperative PRMT5 Inhibitors App 20210079003 - Bobinski; Thomas P. ; et al. | 2021-03-18 |
| MTA-Cooperative PRMT5 Inhibitors App 20210078994 - Bobinski; Thomas P. ; et al. | 2021-03-18 |
| PRC2 Inhibitors App 20210032252 - Marx; Matthew Arnold ; et al. | 2021-02-04 |
| Chemokine Receptor Modulators And Uses Thereof App 20200339539 - Jackson; Jeffrey J. ; et al. | 2020-10-29 |
| Chemokine Receptor Modulators And Uses Thereof App 20200325117 - Jackson; Jeffrey J. ; et al. | 2020-10-15 |
| Kras G12c Inhibitors App 20200308170 - Marx; Matthew Arnold ; et al. | 2020-10-01 |
| Kras G12c Inhibitors App 20200262837 - Marx; Matthew Arnold ; et al. | 2020-08-20 |
| Chemokine Receptor Modulators And Uses Thereof App 20200239480 - Beck; Hilary Plake ; et al. | 2020-07-30 |
| Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof Grant 10,722,514 - Biannic , et al. | 2020-07-28 |
| Chemokine receptor modulators and uses thereof Grant 10,683,280 - Jackson , et al. | 2020-06-16 |
| KRas G12C inhibitors Grant 10,647,715 - Marx , et al. | 2020-05-12 |
| Chemokine receptor modulators and uses thereof Grant 10,604,526 - Beck , et al. | 2020-03-31 |
| Kras G12c Inhibitors App 20190270743 - Marx; Matthew Arnold ; et al. | 2019-09-05 |
| Chemokine Receptor Modulators And Uses Thereof App 20190233397 - Jackson; Jeffrey J. ; et al. | 2019-08-01 |
| Chemokine Receptor Modulators And Uses Thereof App 20190152978 - Beck; Hilary Plake ; et al. | 2019-05-23 |
| Ubiquitin-specific-processing Protease 7 (usp7) Modulators And Uses Thereof App 20190142834 - Biannic; Berenger ; et al. | 2019-05-16 |
| Chemokine receptor modulators and uses thereof Grant 10,246,462 - Beck , et al. | 2019-04-02 |
| Chemokine receptor modulators and uses thereof Grant 10,179,787 - Beck , et al. Ja | 2019-01-15 |
| Chemokine Receptor Modulators And Uses Thereof App 20180072743 - Beck; Hilary Plake ; et al. | 2018-03-15 |
| Chemokine Receptor Modulators And Uses Thereof App 20180072740 - Beck; Hilary Plake ; et al. | 2018-03-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 